CYCLO THERAPEUTICS, INC. — Revenue by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/215ee5d4-d2fa-41ca-9259-6618d5632be2/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $1.1M | 2023-01-01 – 2023-12-31 | evidence 0001437749-24-008181 |
| FY 2022 | $1.4M | 2022-01-01 – 2022-12-31 | evidence 0001437749-23-007064 |
| FY 2021 | $1.6M | 2021-01-01 – 2021-12-31 | evidence 0001437749-22-006039 |
| FY 2020 | $903.4k | 2020-01-01 – 2020-12-31 | evidence 0001437749-21-005946 |
| FY 2019 | $1.0M | 2019-01-01 – 2019-12-31 | evidence 0001437749-20-006520 |
| FY 2018 | $1.0M | 2018-01-01 – 2018-12-31 | evidence 0001437749-19-005049 |
| FY 2017 | $1.2M | 2017-01-01 – 2017-12-31 | evidence 0001437749-19-005049 |
| FY 2016 | $1.5M | 2016-01-01 – 2016-12-31 | evidence 0001213900-17-002534 |
| FY 2015 | $950.5k | 2015-01-01 – 2015-12-31 | evidence 0001213900-16-012052 |
| FY 2014 | $1.6M | 2014-01-01 – 2014-12-31 | evidence 0001213900-15-002163 |
| FY 2013 | $1.7M | 2013-01-01 – 2013-12-31 | evidence 0001213900-14-001241 |
| FY 2012 | $988.0k | 2012-01-01 – 2012-12-31 | evidence 0001213900-13-001067 |
| FY 2011 | $1.0M | 2011-01-01 – 2011-12-31 | evidence 0001213900-12-001186 |
| FY 2010 | $793.4k | 2010-01-01 – 2010-12-31 | evidence 0001213900-12-001186 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CYCLO THERAPEUTICS, INC. — all facts · Net Income · Operating Income